Clinical trialNCT04088630CompletedEarly phase 1Interventional

Fingolimod as a Treatment of Cerebral Edema After Intracerebral Hemorrhage

SponsorWake Forest University Health SciencesEnrollment28Cerebral EdemaIntracerebral HemorrhageIntracerebral Hemorrhage IntraparenchymalIntracerebral Hemorrhage, HypertensiveStroke Hemorrhagic

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to test the safety and effectiveness of a single dose of fingolimod in patients with primary spontaneous intracerebral hemorrhage (ICH).

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Stacey Q Wolfe, MD
Wake Forest University Health Sciences
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Fingolimod →Open-label FingolimodPlacebo

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 7 Aug 2020
Primary completion: 30 Jun 2023
Completion: 5 Jun 2024
Last update posted: 23 Jan 2025
Registered enrollment: 28
Registry id: NCT04088630

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.